ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Adult and Pediatric Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17M10596
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and United States Adult and Pediatric Vaccines Market Report Forecast 2022 2028
BUY CHAPTERS

Global Adult and Pediatric Vaccines Market Research Report 2025

Code: QYRE-Auto-17M10596
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Merck
Novartis
Pfizer Inc
Astrazeneca plc
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
SINOVAC BIOTECH

Adult and Pediatric Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Adult and Pediatric Vaccines Market

Adult and Pediatric Vaccines Market

The global market for Adult and Pediatric Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.
The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adult and Pediatric Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Adult and Pediatric Vaccines Market Report

Report Metric Details
Report Name Adult and Pediatric Vaccines Market
CAGR 5%
Segment by Type
  • Adult Vaccines
  • Pediatric Vaccines
Segment by Application
  • Hospitals
  • Medical Care Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical, Bavarian Nordic, LG Life Sciences, Sinovac Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Adult and Pediatric Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adult and Pediatric Vaccines Market report?

Ans: The main players in the Adult and Pediatric Vaccines Market are GlaxoSmithKline, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Johnson and Johnson, Takeda Pharmaceutical, Bavarian Nordic, LG Life Sciences, Sinovac Biotech

What are the Application segmentation covered in the Adult and Pediatric Vaccines Market report?

Ans: The Applications covered in the Adult and Pediatric Vaccines Market report are Hospitals, Medical Care Centers, Others

What are the Type segmentation covered in the Adult and Pediatric Vaccines Market report?

Ans: The Types covered in the Adult and Pediatric Vaccines Market report are Adult Vaccines, Pediatric Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adult Vaccines
1.2.3 Pediatric Vaccines
1.3 Market by Application
1.3.1 Global Adult and Pediatric Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adult and Pediatric Vaccines Market Perspective (2020-2031)
2.2 Global Adult and Pediatric Vaccines Growth Trends by Region
2.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Adult and Pediatric Vaccines Market Dynamics
2.3.1 Adult and Pediatric Vaccines Industry Trends
2.3.2 Adult and Pediatric Vaccines Market Drivers
2.3.3 Adult and Pediatric Vaccines Market Challenges
2.3.4 Adult and Pediatric Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adult and Pediatric Vaccines Players by Revenue
3.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2020-2025)
3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adult and Pediatric Vaccines Revenue
3.4 Global Adult and Pediatric Vaccines Market Concentration Ratio
3.4.1 Global Adult and Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult and Pediatric Vaccines Revenue in 2024
3.5 Global Key Players of Adult and Pediatric Vaccines Head office and Area Served
3.6 Global Key Players of Adult and Pediatric Vaccines, Product and Application
3.7 Global Key Players of Adult and Pediatric Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult and Pediatric Vaccines Breakdown Data by Type
4.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031)
5 Adult and Pediatric Vaccines Breakdown Data by Application
5.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adult and Pediatric Vaccines Market Size (2020-2031)
6.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
6.4 North America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adult and Pediatric Vaccines Market Size (2020-2031)
7.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025)
7.4 Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adult and Pediatric Vaccines Market Size (2020-2031)
9.2 Latin America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
9.4 Latin America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction
11.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Adult and Pediatric Vaccines Introduction
11.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Adult and Pediatric Vaccines Introduction
11.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Adult and Pediatric Vaccines Introduction
11.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Adult and Pediatric Vaccines Introduction
11.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction
11.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Company Details
11.7.2 Johnson and Johnson Business Overview
11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction
11.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.7.5 Johnson and Johnson Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction
11.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 Bavarian Nordic
11.9.1 Bavarian Nordic Company Details
11.9.2 Bavarian Nordic Business Overview
11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction
11.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.9.5 Bavarian Nordic Recent Development
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Details
11.10.2 LG Life Sciences Business Overview
11.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction
11.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.10.5 LG Life Sciences Recent Development
11.11 Sinovac Biotech
11.11.1 Sinovac Biotech Company Details
11.11.2 Sinovac Biotech Business Overview
11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction
11.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025)
11.11.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Merck
Novartis
Pfizer Inc
Astrazeneca plc
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
SINOVAC BIOTECH
List of Tables
 Table 1. Global Adult and Pediatric Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adult Vaccines
 Table 3. Key Players of Pediatric Vaccines
 Table 4. Global Adult and Pediatric Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Adult and Pediatric Vaccines Market Share by Region (2020-2025)
 Table 8. Global Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Adult and Pediatric Vaccines Market Share by Region (2026-2031)
 Table 10. Adult and Pediatric Vaccines Market Trends
 Table 11. Adult and Pediatric Vaccines Market Drivers
 Table 12. Adult and Pediatric Vaccines Market Challenges
 Table 13. Adult and Pediatric Vaccines Market Restraints
 Table 14. Global Adult and Pediatric Vaccines Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Adult and Pediatric Vaccines Market Share by Players (2020-2025)
 Table 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2024)
 Table 17. Ranking of Global Top Adult and Pediatric Vaccines Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Adult and Pediatric Vaccines Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Adult and Pediatric Vaccines, Headquarters and Area Served
 Table 20. Global Key Players of Adult and Pediatric Vaccines, Product and Application
 Table 21. Global Key Players of Adult and Pediatric Vaccines, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Adult and Pediatric Vaccines Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2020-2025)
 Table 25. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2026-2031)
 Table 27. Global Adult and Pediatric Vaccines Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2020-2025)
 Table 29. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2026-2031)
 Table 31. North America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Adult and Pediatric Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Adult and Pediatric Vaccines Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Adult and Pediatric Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 46. GlaxoSmithKline Company Details
 Table 47. GlaxoSmithKline Business Overview
 Table 48. GlaxoSmithKline Adult and Pediatric Vaccines Product
 Table 49. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 50. GlaxoSmithKline Recent Development
 Table 51. Sanofi Company Details
 Table 52. Sanofi Business Overview
 Table 53. Sanofi Adult and Pediatric Vaccines Product
 Table 54. Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 55. Sanofi Recent Development
 Table 56. Merck Company Details
 Table 57. Merck Business Overview
 Table 58. Merck Adult and Pediatric Vaccines Product
 Table 59. Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 60. Merck Recent Development
 Table 61. Novartis Company Details
 Table 62. Novartis Business Overview
 Table 63. Novartis Adult and Pediatric Vaccines Product
 Table 64. Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 65. Novartis Recent Development
 Table 66. Pfizer Company Details
 Table 67. Pfizer Business Overview
 Table 68. Pfizer Adult and Pediatric Vaccines Product
 Table 69. Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 70. Pfizer Recent Development
 Table 71. AstraZeneca Company Details
 Table 72. AstraZeneca Business Overview
 Table 73. AstraZeneca Adult and Pediatric Vaccines Product
 Table 74. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 75. AstraZeneca Recent Development
 Table 76. Johnson and Johnson Company Details
 Table 77. Johnson and Johnson Business Overview
 Table 78. Johnson and Johnson Adult and Pediatric Vaccines Product
 Table 79. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 80. Johnson and Johnson Recent Development
 Table 81. Takeda Pharmaceutical Company Details
 Table 82. Takeda Pharmaceutical Business Overview
 Table 83. Takeda Pharmaceutical Adult and Pediatric Vaccines Product
 Table 84. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 85. Takeda Pharmaceutical Recent Development
 Table 86. Bavarian Nordic Company Details
 Table 87. Bavarian Nordic Business Overview
 Table 88. Bavarian Nordic Adult and Pediatric Vaccines Product
 Table 89. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 90. Bavarian Nordic Recent Development
 Table 91. LG Life Sciences Company Details
 Table 92. LG Life Sciences Business Overview
 Table 93. LG Life Sciences Adult and Pediatric Vaccines Product
 Table 94. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 95. LG Life Sciences Recent Development
 Table 96. Sinovac Biotech Company Details
 Table 97. Sinovac Biotech Business Overview
 Table 98. Sinovac Biotech Adult and Pediatric Vaccines Product
 Table 99. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
 Table 100. Sinovac Biotech Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Adult and Pediatric Vaccines Picture
 Figure 2. Global Adult and Pediatric Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Adult and Pediatric Vaccines Market Share by Type: 2024 VS 2031
 Figure 4. Adult Vaccines Features
 Figure 5. Pediatric Vaccines Features
 Figure 6. Global Adult and Pediatric Vaccines Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Adult and Pediatric Vaccines Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Medical Care Centers Case Studies
 Figure 10. Others Case Studies
 Figure 11. Adult and Pediatric Vaccines Report Years Considered
 Figure 12. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Adult and Pediatric Vaccines Market Share by Region: 2024 VS 2031
 Figure 15. Global Adult and Pediatric Vaccines Market Share by Players in 2024
 Figure 16. Global Top Adult and Pediatric Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Adult and Pediatric Vaccines Revenue in 2024
 Figure 18. North America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
 Figure 20. United States Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Adult and Pediatric Vaccines Market Share by Country (2020-2031)
 Figure 24. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Adult and Pediatric Vaccines Market Share by Region (2020-2031)
 Figure 32. China Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
 Figure 40. Mexico Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Adult and Pediatric Vaccines Market Share by Country (2020-2031)
 Figure 44. Turkey Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 48. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 49. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 52. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 53. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 55. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 56. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 57. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Adult Vaccines Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Global Seasonal Vaccines Market Research Report 2024
Global Infant and Child Multiple Vaccine Market Research Report 2024
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Consumption Type Vaccine Market Research Report 2024
Global HIV Vaccine Market Research Report 2025
Global Multiple Vaccine Market Research Report 2024
Human Vaccine Adjuvants Market
Global Live Vaccines Market Research Report 2024
Global Vaccines For Children Market Insights Forecast to 2030
Global HIV and AIDS Vaccine Market Research Report 2024
Paediatric Vaccine Market
Global Vaccination Device Market Research Report 2024
Global Norovirus Vaccine Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024
Global Biopharmaceutical and Vaccines Market Research Report 2024
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions